Over-the-counter drug · UNAPPROVED DRUG OTHER
Obagi-C C-Rx System Normal-Dry Skin Intervention NDC 62032-916
hydroquinone, homosalate, octisalate, zinc oxide · Kit · Obagi Cosmeceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 62032-916-01 | 6203209160162032091601 | 1 KIT in 1 CARTON (62032-916-01) * 1 TUBE in 1 CARTON (62032-140-09) / 85 g in 1 TUBE * 177 mL in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC (62032-105-36) * 1 BOTTLE, GLASS in 1 CARTON (62032-106-10) / 30 mL in 1 BOTTLE, GLASSMarketed from Jun 25, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Obagi-C C-Rx System Normal-Dry Skin Intervention
- Generic name (nonproprietary)
- hydroquinone, homosalate, octisalate, zinc oxide
- Dosage form
- Kit
- Labeler
- Obagi Cosmeceuticals LLCNDC labeler code 62032
- Product type
- Over-the-counter drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Identifiers
- Product ID 62032-916_8562c1e2-2e0a-4aba-911a-dd89f1c59b4aSPL ID 8562c1e2-2e0a-4aba-911a-dd89f1c59b4aSPL set ID ca931d1c-4df4-47ce-8d5c-cd8c3e38c02bRxCUI 197795
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N462032091601followed by a unit qualifier and the quantityPackage 62032-0916-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Uses helps prevent sunburn If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
Excerpt only. Read the full label for complete information.
About NDC 62032-916
- What is NDC 62032-916?
- 62032-916 is the product NDC for Obagi-C C-Rx System Normal-Dry Skin Intervention kit, listed with the FDA by Obagi Cosmeceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Obagi-C C-Rx System Normal-Dry Skin Intervention (Hydroquinone, Homosalate, Octisalate, Zinc oxide).
- Who is the labeler?
- Obagi Cosmeceuticals LLC, NDC labeler code 62032. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Obagi-C C-Rx System Normal-Dry Skin Intervention?
- 1 other product NDC are listed under this name. See all Obagi-C C-Rx System Normal-Dry Skin Intervention NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Obagi-C C-Rx System Normal-Dry Skin Intervention products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Obagi-C C-Rx System Normal-Dry Skin Interventionhydroquinone, titanium dioxide, zinc oxide | — | Kit | Obagi Cosmeceuticals LLC | 62032-922 | 62032-0922-01 |